Nu Skin Enterprises Inc (NUS) Class A Com Stk USD 0.001

Sell:$6.12Buy:$6.14Price decreased$0.16 (2.55%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$6.12
Buy:$6.14
Change:Price decreased$0.16 (2.55%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$6.12
Buy:$6.14
Change:Price decreased$0.16 (2.55%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its beauty & skincare solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lines and wrinkles, and oily skin and pores. Its health & wellness solutions include gut health, bone and joint health, brain health, energy and stamina, heart health, immunity support, and protein and fitness. It offers various beauty devices, including ageLOC LumiSpa, Nu Skin RenuSpa iO and Prysm iO. Its ageLOC LumiSpa includes products such as LumiSpa iO Superpower Kit, ageLOC Rose Gold LumiSpa iO, LumiSpa Rose Gold Accent Twin Pack, and others.

Key people

Steven J. Lund
Executive Chairman of the Board
James M. Winett
Independent Director
Ryan S. Napierski
President, Chief Executive Officer, Director
Chelsea Lantz
Interim Chief Financial Officer
Chayce D. Clark
Executive Vice President, Chief Operating Officer, Chief Legal Officer
Justin S. Keisel
Executive Vice President and President of Global Sales
Daniel W. Campbell
Lead Independent Director
Emma S. Battle
Independent Director
Laura Nathanson
Independent Director
Thomas R. Pisano
Independent Director
Click to see more

Key facts

  • Shares in issue
    90.55m
  • EPIC
    NUS
  • ISIN
    US67018T1051
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Major Drugs
  • Market cap
    $297.13m
  • Employees
    2,800
  • Exchange
    New York Stock Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.